Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

• Status: Terminated
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

• To assess the effect of a long-term treatment by Genotonorm on linear growth in children with short stature receiving steroid therapy

• To assess the effect of a long term treatment with Genotonorm on bone mineralisation

• To assess the effect of a long term treatment with Genotonorm on body composition

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Hormones

Criteria

Inclusion Criteria:

• Children with juvenile arthritis or nephrotic syndrome

• Before or during puberty

Exclusion Criteria:

• Diabetes Type 1 and 2

• Endocrine disease, except well substituted hypothyroidism